Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2024 Jul 16;332(3):215-225.
doi: 10.1001/jama.2024.8469.

Kidney Transplant Outcomes From Deceased Donors Who Received Dialysis

Affiliations
Comparative Study

Kidney Transplant Outcomes From Deceased Donors Who Received Dialysis

Yumeng Wen et al. JAMA. .

Abstract

Importance: Recipient outcomes after kidney transplant from deceased donors who received dialysis prior to kidney donation are not well described.

Objective: To compare outcomes of transplant recipients who received kidneys from deceased donors who underwent dialysis prior to kidney donation vs recipients of kidneys from deceased donors who did not undergo dialysis.

Design, setting, and participants: A retrospective cohort study was conducted including data from 58 US organ procurement organizations on deceased kidney donors and kidney transplant recipients. From 2010 to 2018, 805 donors who underwent dialysis prior to kidney donation were identified. The donors who underwent dialysis prior to kidney donation were matched 1:1 with donors who did not undergo dialysis using a rank-based distance matrix algorithm; 1944 kidney transplant recipients were evaluated.

Exposure: Kidney transplants from deceased donors who underwent dialysis prior to kidney donation compared with kidney transplants from deceased donors who did not undergo dialysis.

Main outcomes and measures: The 4 study outcomes were delayed graft function (defined as receipt of dialysis by the kidney recipient ≤1 week after transplant), all-cause graft failure, death-censored graft failure, and death.

Results: From 2010 to 2018, 1.4% of deceased kidney donors (805 of 58 155) underwent dialysis prior to kidney donation. Of these 805 individuals, 523 (65%) donated at least 1 kidney. A total of 969 kidneys (60%) were transplanted and 641 kidneys (40%) were discarded. Among the donors with kidneys transplanted, 514 (mean age, 33 years [SD, 10.8 years]; 98 had hypertension [19.1%] and 36 had diabetes [7%]) underwent dialysis prior to donation and were matched with 514 (mean age, 33 years [SD, 10.9 years]; 98 had hypertension [19.1%] and 36 had diabetes [7%]) who did not undergo dialysis. Kidney transplants from donors who received dialysis prior to donation (n = 954 kidney recipients) were associated with a higher risk of delayed graft function compared with kidney transplants from donors who did not receive dialysis (n = 990 kidney recipients) (59.2% vs 24.6%, respectively; adjusted odds ratio, 4.17 [95% CI, 3.28-5.29]). The incidence rates did not significantly differ at a median follow-up of 34.1 months for all-cause graft failure (43.1 kidney transplants per 1000 person-years from donors who received dialysis prior to donation vs 46.9 kidney transplants per 1000 person-years from donors who did not receive dialysis; adjusted hazard ratio [HR], 0.90 [95% CI, 0.70-1.15]), for death-censored graft failure (22.5 vs 20.6 per 1000 person-years, respectively; adjusted HR, 1.18 [95% CI, 0.83-1.69]), or for death (24.6 vs 30.8 per 1000 person-years; adjusted HR, 0.76 [95% CI, 0.55-1.04]).

Conclusions and relevance: Compared with receiving a kidney from a deceased donor who did not undergo dialysis, receiving a kidney from a deceased donor who underwent dialysis prior to kidney donation was associated with a significantly higher incidence of delayed graft function, but no significant difference in graft failure or death at follow-up.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Wen reported being an employee of Genentech and having stock and stock and stock options in Roche at the time of final manuscript revision. Dr Mohan reported receiving personal fees from the International Society of Nephrology, Sanofi, and the Health Services Advisory Group; receiving grants from the National Institutes of Health; serving as chair for the United Network for Organ Sharing data advisory committee and for the Scientific Registry of Transplant Recipients review committee; and being the deputy editor of Kidney International Reports. Dr Reese reported receiving grant support from Merck, AbbVie, and Gilead related to transplanting organs from hepatitis C virus–infected donors and from eGenesis to develop xenotransplant treatment and being an associate editor of the American Journal of Kidney Disease. Dr Parikh reported receiving personal fees from Alexion and Otsuka. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Identification and Adjudication Process for Deceased Donors by Dialysis Status, Matching, and Linkage to Kidney Transplant Recipients
aIntoxication with methanol, ethylene glycol, lithium, or other substances or medications. bIncludes dialysis for severe hyperkalemia, acidosis, hypervolemia, hyperammonemia, and other electrolyte abnormalities without laboratory evidence of stage 2 to 3 acute kidney injury.
Figure 2.
Figure 2.. Geographic Variation in Kidney Transplants From Deceased Donors Who Underwent Dialysis Across 58 Donation Service Areas in the US From 2010 to 2018
Geographical heat map depicting rates and locations of kidneys transplanted from deceased donors who underwent dialysis during their final hospitalization.
Figure 3.
Figure 3.. Recipient Short- and Longer-Term Outcomes After Kidney Transplant From Matched Deceased Donors
HR indicates hazard ratio; OR, odds ratio. aThe data in column 4 are adjusted ORs (95% CIs). Short-term is defined as within 7 days after kidney transplant. bFor the kidney recipient comparisons by matched donor dialysis status (underwent dialysis vs did not undergo dialysis), logistic and Cox proportional hazard regression models were used and adjusted for the following covariates: cold ischemic time, recipient age, body mass index, diabetes as the cause of recipient end-stage kidney disease, preemptive transplant status, previous kidney transplant, level of human leukocyte antigen mismatch, panel reactive antibody category (0%, 1%-20%, 21%-80%, and >80%), and donor estimated glomerular filtration rate at hospital admission. Sandwich estimators were used to account for outcome dependency when both donor kidneys were explanted. cIncludes dialysis for severe hyperkalemia, acidosis, hypervolemia, hyperammonemia, and other electrolyte abnormalities without laboratory evidence of stage 2 or 3 acute kidney injury. dThe data in column 4 are adjusted HRs (95% CIs).
Figure 4.
Figure 4.. Kaplan-Meier Survival Curves of Longer-Term Outcomes for Recipients After Kidney Transplant From Matched Donors by Dialysis Status

Comment in

References

    1. US Department of Health and Human Services . OPTN/SRTR 2020 annual data report. Accessed May 6, 2024. https://srtr.transplant.hrsa.gov/annual_reports/2020_ADR_Preview.aspx
    1. US Department of Health and Human Services . OPTN: national data. Accessed January 18, 2022. https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/
    1. Mansour SG, Khoury N, Kodali R, et al. . Clinically adjudicated deceased donor acute kidney injury and graft outcomes. PLoS One. 2022;17(3):e0264329. - PMC - PubMed
    1. Reese PP, Hall IE, Weng FL, et al. . Associations between deceased-donor urine injury biomarkers and kidney transplant outcomes. J Am Soc Nephrol. 2016;27(5):1534-1543. - PMC - PubMed
    1. Hall IE, Akalin E, Bromberg JS, et al. . Deceased-donor acute kidney injury is not associated with kidney allograft failure. Kidney Int. 2019;95(1):199-209. - PMC - PubMed

Publication types